Key result
Automated electrophysiology method compares voltage and frequency dependence of ion channel blockers using real-time compensation.
Why the study?
Drug discovery programs require reliable methods to rank use dependence of voltage-gated ion channel blockers with compensation for voltage errors and electrode drift.
A novel automated electrophysiology method enables more accurate characterization and ranking of use-dependent ion channel blockers for drug discovery.
May enable precise ranking of use-dependent blockers in discovery; leaves open validation for therapeutic translation.
Ion channels are important therapeutic targets for the treatment of a variety of conditions. Among ion channel blocking agents, use-dependent inhibitors can be especially effective therapeutic agents. Use dependence allows the selective inhibition of hyperactive neurons or tachycardiac myocytes, while minimizing effects on cells with normal activity. For voltage-gated channels, the use-dependent compounds typically bind to and inhibit a particular kinetic state that is induced by specific voltage changes. Drug discovery programs that focus on this class of drugs need to rank the use dependence of the compounds. A meaningful comparison among different molecules requires voltage clamp-based assays with continuous voltage control and compensation for or elimination of electrode drift-related effects. A method was developed based on automated electrophysiology in which voltage and frequency dependence of voltage-gated ion channel blockers can be compared using a protocol in which voltage error is compensated for in real time.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2006) studied this question. Automated electrophysiology method with real-time voltage error compensation was evaluated on Development of a method to compare voltage and frequency dependence of voltage-gated ion channel blockers. A method based on automated electrophysiology was developed to compare the voltage and frequency dependence of voltage-gated ion channel blockers using real-time voltage error compensation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: